Sahlgrenska University Hospital, Gothenburg

Sweden

Sahlgrenska

Contact Information for physicians and patients

https://www.sahlgrenska.se/for-dig-som-ar/vardgivare/
https://www.sahlgrenska.se/for-dig-som-ar/patient/

Overview

Particular rare liver disease expertise of the centre

  • Primary Biliary Cholangitis (PBC)
  • Autoimmune Hepatitis (AIH)
  • Primary Sclerosing Cholangitis (PSC)
  • IgG4-related Liver Disease
  • Genetic Cholestatic Disease
  • Progressive familial intrahepatic cholestasis (PFIC)
  • Wilson Disease
  • Alpha-1-Antitrypsin Deficiency (A1ATD)
  • Isolated Biliary Atresia
  • Choledochal Cyst
  • Cystic Liver Disease
  • Vascular Liver Disease
  • Intrahepatic Cholangiocarcinoma
  • Intrahepatic cholestasis of pregnancy

ERN Representatives

  • Maria Antonella Burza, MD, PhD

  • Johan Waern

ERN Team and Contact

The hospital’s ERN / R&D representatives

  • Catarina Finizia caterina.finizia(at)vgregion.se
  • Lars Grip lars.grip(at)vgregion.se

Centre information

Sahlgrenska University Hospital (SU) provides emergency and basic care for the Göteborg region, and its 700,000 inhabitants, and highly specialised care for West Sweden, with 1.7 million inhabitants. SU is also the country´s centre for certain specialised care, especially in paediatrics (paediatric heart surgery, incubator care for premature babies, as well as the treatment in paediatric endocrinology). SU is also well known for its successful transplant activity (the only centre in Sweden performing liver, pancreas, kidney, heart, lung, and multivisceral transplantations) treatment of cardio-vascular diseases, immunology (research into rejection mechanisms) as well as research into vaccines. 
SU is one of six teaching hospitals with medical education in Sweden. The hospital provides an infrastructure necessary for teaching and research in cooperation with the Sahlgrenska Academy at the University of Gothenburg.

Overview